Product Images Oxcarbazepine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Oxcarbazepine NDC 70518-4079 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

MM2 - OXcarbazepine 300mg 70518 4079 01

MM2 - OXcarbazepine 300mg 70518 4079 01

Oxcarbazepine is available in tablet form with a strength of 300 mg, packaged in a box of 100 tablets. It is a prescription medication with an NDC number of 70518-4079-01. The manufacturer is Advagen Pharma Limited, located in Plainsboro, NJ. Storage instructions advise keeping the medication at 20-25°C (58-77°F) with permissible excursions to 15.30°C (59-86°F) as per USP standards. For detailed usage instructions, refer to the package insert. Additionally, the medication has been repackaged by RemedyRepack Inc. located in Indiana, PA.*

MM3 - OXcarbazepine 300mg 70518 4079 02

MM3 - OXcarbazepine 300mg 70518 4079 02

This text provides information about the medication Oxcarbazepine in 300mg tablet form. It includes details such as the NDC number, manufacturing source, storage directions, and contact information for the repackaging company Remedy Repack. The package insert should be referred to for detailed directions on usage.*

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

This is information regarding Oxcarbazepine 300mg tablets, quantity of 30 tablets. It includes details such as the NDC number, expiration date, manufacturer (Advagen Pharma Limited), storage instructions, and the repackaging information by RemedyRepack Inc. It is a prescription medication indicated for specific medical conditions.*

Figure 1 Kaplan-Meier Estimates of Exit Rate by Treatment Group. - oxcarbazepine tabs usp fig1

Figure 1 Kaplan-Meier Estimates of Exit Rate by Treatment Group. - oxcarbazepine tabs usp fig1

Figure 2 Kaplan-Meier Estimates of First Seizure Event Rate by Treatment Group. - oxcarbazepine tabs usp fig2

Figure 2  Kaplan-Meier Estimates of First Seizure Event Rate by Treatment Group. - oxcarbazepine tabs usp fig2

Figure 3 Kaplan-Meier Estimates of Exit Rate by Treatment Group. - oxcarbazepine tabs usp fig3

Figure 3  Kaplan-Meier Estimates of Exit Rate by Treatment Group. - oxcarbazepine tabs usp fig3

Figure 4 Kaplan-Meier Estimates of Exit Rate by Treatment Group. - oxcarbazepine tabs usp fig4

Figure 4  Kaplan-Meier Estimates of Exit Rate by Treatment Group. - oxcarbazepine tabs usp fig4

Oxcarbazepine structural formula. - oxcarbazepine tabs usp structural formula

Oxcarbazepine structural formula. - oxcarbazepine tabs usp structural formula

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.